LifeSci Biotechnology Clinical Trials Index ETF Overview

With 1 ETFs traded in the U.S. markets, LifeSci Biotechnology Clinical Trials Index ETFs gather total assets under management of $26.71M. The average expense ratio is 0.79%. LifeSci Biotechnology Clinical Trials Index ETFs can be found in the following asset classes:

  • Equity

Daily ETF Watch

First Trust Plans ‘SMID’ Dividend ETF

New small/midcap fund will target stocks exhibiting steady dividend growth.

Features and News

2 Key Drivers Behind Biotech ETF Rally

The segment is delivering some impressive gains after a bout of investor doubt.

Features and News

Worst Performing ETFs Of 2016

These 10 ETFs dropped by 30% or more despite a rally in the broad market.

Features and News

ETF Portfolio X-Ray: Toroso's Neutral Allocation Strategy

In this series, we look under the hood of some of the ETF portfolios in the market today.

Daily ETF Watch

ETF Watch: iShares Debuts Socially Responsible Funds

New funds focus on environmental, social and governance standards for investing in emerging and developed markets.

Features and News

Surprising ETF Losers Of 2016

These three popular slices of the ETF universe are faring poorly this year.

Features and News

Worst Performing ETFs Of 2016 To Date

It's still early in the year, but a number of ETFs have already lost 25-50% of their value in 2016.

Features and News

Volatility: Ignore It Or Exploit It?

If a wild ride is in store for U.S. equity investors, here are some thoughts to consider.

Features and News

Top ETF Strategist Picks For 2016

Here are some favorite funds that advisors like going into the new year.